Point72 Hong Kong Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$108,000
+125.0%
25,518
+205.4%
0.00%
+100.0%
Q1 2022$48,000
-34.2%
8,355
+23.1%
0.00%0.0%
Q3 2021$73,000
+135.5%
6,787
+241.1%
0.00%
+100.0%
Q2 2021$31,000
+1450.0%
1,990
+1024.3%
0.00%0.0%
Q1 2020$2,000
+100.0%
177
+276.6%
0.00%
Q3 2018$1,000
-98.7%
47
-97.7%
0.00%
-100.0%
Q2 2018$79,0002,0240.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders